Working... Menu
Trial record 12 of 59 for:    Inclusion Body Myositis

Double-blind, Randomized, Placebo-controlled Trial of Etanercept for 12 Months in Subjects With Inclusion Body Myositis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00802815
Recruitment Status : Completed
First Posted : December 5, 2008
Last Update Posted : May 29, 2014
Information provided by (Responsible Party):
Glenn Lopate, Washington University School of Medicine

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : May 2014
  Actual Study Completion Date : May 2014